All Search Results
-
Some advice to my younger self about being a new mother
My husband and I are having another baby- a little boy- due in February. Our firstborn son is 10 years old, so our boys will be a decade apart. I often think about going through this for a second time, 10 years older than before. Knowing what I know now, I wish I could tell my younger self a few things.
-
How one physical therapist overcame scoliosis and now helps children do the same
My Story
-
Turkey Dinner on the Lawn? Creative Ways to Celebrate the Holidays in 2020
For many Americans, family gatherings are a holiday tradition. During uncertain times such as these, getting together can provide a significant boost to psychological and social well-being. With some mindfulness and creativity, you can look forward to celebrating the holidays this year, despite the COVID-19 pandemic. You’ll need to contemplate who will be attending (number of people, ages, where they live, physical distancing), where the event will occur and what it will entail.
-
Oncofertility Program
Many pediatric cancer survivors wish to start families and have children of their own one day. But some cancer treatments can affect a child's fertility (ability to have future children). This is why it is important to think about your child's fertility before cancer treatment starts.
-
A 4-Week, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Tenapanor for the Treatment of Irritable Bowel Syndrome with Constipation (IBS-C) in Pediatric Patients 6 to Less than 12 Years Old
A 4-Week, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Tenapanor for the Treatment of Irritable Bowel Syndrome with Constipation (IBS-C) in Pediatric Patients 6 to Less than 12 Years Old
-
Project:EveryChild - A Registry, Eligibility Screening, Biology and Outcome Study
Project: EveryChild a Registry, Eligibility Screening, Biology and Outcome Study
-
Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Treatment of Newly Diagnosed Diffuse Anaplastic Wilms Tumors (DAWT) and Relapsed Favorable Histology Wilms Tumors (FHWT)
-
Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours (P3BEP)
AGCT1532 - Phase 3 Accelerated BEP: A Randomised Phase 3 Trial of Accelerated Versus Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours
-
Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma
Phase II Trial of Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma
-
DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
Phase II Trial of Eflornithine/DFMO as Maintenance Therapy for Molecular High Risk/Very High Risk and Relapsed/Refractory Medulloblastoma
